Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease

Published:2016-02 Issue: Volume:26 Page:87-95
ISSN:1471-4892
Container-title:Current Opinion in Pharmacology
language:en
Short-container-title:Current Opinion in Pharmacology

Author:

Olson Katherine E,Gendelman Howard E

Funder

University of Nebraska Foundation

National Institutes of Health

Department of Defense

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference79 articles.

1. The scientific and clinical basis for the treatment of Parkinson disease (2009);Olanow;Neurology,2009

2. Inflammation and adaptive immunity in Parkinson's disease;Mosley;Cold Spring Harb Perspect Med,2012

3. Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders;Anderson;Transl Neurodegener,2014

4. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention;Liu;J Pharmacol Exp Ther,2003

5. Peripheral inflammatory biomarkers and risk of Parkinson's disease;Chen;Am J Epidemiol,2008

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the possibilities of therapeutic potential of silymarin and silibinin against neurodegenerative Diseases-A mechanistic overview;European Journal of Pharmacology;2024-10

2. Immunomodulation as a treatment for Parkinson�s disease in current trials: a systematic review and meta-analysis;Revista de investigaci�n Cl�nica;2024-07-12

3. Pimecrolimus protects neuron‐like SH‐SY5Y cells against anti‐inflammatory and anti‐oxidant effects of both microglial secretome and hydrogen peroxide;Scandinavian Journal of Immunology;2023-09-11

4. Network pharmacology-based identification of potential inhibitor(s) against phospholipase A2;Phospholipases in Physiology and Pathology;2023

5. Neuroinflammation, immune response and α-synuclein pathology: how animal models are helping us to connect dots;Expert Opinion on Drug Discovery;2022-12-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3